Advertisement
Organisation › Details
ArchiMed MED I Fund
Founded by Denis Ribon, previously Global Head of Healthcare at 3i, and his fellow Managing Partners, Vincent Guillaumot – another former 3i healthcare executive – and Robin Filmer-Wilson, a former 3i healthcare co-investor, ArchiMed is an independent private equity team 100% dedicated to the healthcare sector in Europe. The Managing Partners are currently investing from the €150 million Med 1 fund. The ArchiMed team also includes Operating Partner Loïc Kubitza, previously a Leader at PwC’s Healthcare and Life Sciences Practice, and Operating Partner Christoph Böhmer, formerly a McKinsey partner and Managing Director of €1 billion-in-revenues cardiovascular leader Biotronik. ArchiMed invests in all healthcare sectors, targeting profitable, established European healthcare companies and investing between €5 million and €30 million per transaction. ArchiMed engages in both unleveraged growth investments and leveraged buyouts. In the last sixteen years, the ArchiMed team has invested more than €1 billion in 20-plus companies, achieving a total return of over 2.6 times invested capital. *
Start | 2014-01-01 fund closing | |
Group | ArchiMed (Group) | |
Successor | ArchiMed MED II Fund | |
Industry | ArchiMed MED I Fund | |
Industry 2 | healthcare | |
Region | Lyon | |
Country | France | |
City | 69003 Lyon | |
Tel | +33-4-8111-35 33 | |
Address record changed: 2023-12-04 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 150,000,000 (fund size at closing (2014) 2014-01-01) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for ArchiMed (Group)
- [1] ArchiMed S.A.S.. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist"....
- [2] ArchiMed S.A.S.. (11/3/21). "Press Release: ArchiMed Buys Cube, an Innovative Provider of Membrane Protein Services for the Biopharma Research Market"....
- [3] ArchiMed S.A.S.. (10/5/21). "Press Release: ArchiMed Backs Xpress Biologics, a Leading Provider of Plasmid DNA for Advanced Therapy Medicinal Products"....
- [4] Clean Cells S.A.S.. (9/15/21). "Press Release: Clean Cells Invests over €13M in New Biopharmaceutical Production Site". Montaigu-Vendée, near Nantes....
- [5] ArchiMed S.A.S.. (8/5/21). "Press Release: ArchiMed Closes MED III at €650 Million Hard Cap in Less than Two Months"....
- [6] ArchiMed S.A.S.. (1/12/21). "Press Release: ArchiMed Buys Germany’s Zyto Group of Cancer Diagnostics Companies in Partnership with Owners and Management"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top